<DOC>
	<DOCNO>NCT02095353</DOCNO>
	<brief_summary>The investigator propose analyze perfusion ( blood flow ) characteristic blood tumor . The investigator compare use two contrast agent study .</brief_summary>
	<brief_title>Comparison Contrast Agents MRI Perfusion Analysis Brain Tumor Patients</brief_title>
	<detailed_description />
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<criteria>Subjects brain tumor enrol . These subject may newly diagnose , undergo treatment undergoing followup . If subject undergone surgery treatment appear residual tumor . Renal failure ( GFR &lt; 45 ) . Subjects screen utilizing UNMC gadolinium contrast guideline . Allergic reaction MRI contrast agent . Subjects fit criterion population evaluate . Subjects participate study follow condition : Anxiety attack Panic disorder Claustrophobia Pregnant , try become pregnant Breast feeding Subjects participate study certain kind metal body , example : heart pacemaker , defibrillator , neurostimulator , metal plate , certain otologic implant , certain type heart valve , metal sliver eye , brain aneurysm clip metal sliver bullet fragment near certain structure body . Our standard MRI safety screen performed subject . If subject metal body require additional xray beyond need clinical MRI examination safely perform research MRI examination subject would excluded.Subjects able return followup examination</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Brain tumor</keyword>
	<keyword>extraaxial</keyword>
	<keyword>metastasis</keyword>
	<keyword>glioma</keyword>
	<keyword>primary brain tumor</keyword>
	<keyword>secondary brain tumor</keyword>
	<keyword>MRI</keyword>
	<keyword>perfusion</keyword>
	<keyword>dynamic contrast enhancement</keyword>
	<keyword>CBV</keyword>
	<keyword>CBF</keyword>
	<keyword>ktrans</keyword>
</DOC>